Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
IMMUNOGENICITY OF SUBCUTANEOUS AND INTRAVENOUS TOCILIZUMAB AS MONOTHERAPY OR IN COMBINATION WITH DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS IN RHEUMATOID ARTHRITIS Genovese, M. C., Ogata, A., Nomura, A., Bao, M., Hitraya, E., Lacey, S., Burmester, G. R. OXFORD UNIV PRESS. 2016: 92–93
View details for Web of Science ID 000376656000242